Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of CHAMPIONS ONCOLOGY, INC. from Q1 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Champions Oncology, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q1 2022 to Q2 2025.
  • Champions Oncology, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending July 31, 2025 was $4.66M, a 24.9% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

CHAMPIONS ONCOLOGY, INC. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $4.66M -$1.54M -24.9% Jul 31, 2025 10-Q 2025-09-15
Q1 2025 $5.04M -$1.56M -23.7% Apr 30, 2025 10-K 2025-07-23
Q4 2024 $5.42M -$1.59M -22.6% Jan 31, 2025 10-Q 2025-03-17
Q3 2024 $5.81M -$1.6M -21.6% Oct 31, 2024 10-Q 2024-12-16
Q2 2024 $6.2M -$1.62M -20.7% Jul 31, 2024 10-Q 2024-09-13
Q1 2024 $6.6M -$1.62M -19.7% Apr 30, 2024 10-K 2024-07-19
Q4 2023 $7M -$1.64M -18.9% Jan 31, 2024 10-Q 2024-03-15
Q3 2023 $7.41M -$1.84M -19.9% Oct 31, 2023 10-Q 2023-12-13
Q2 2023 $7.82M -$1.6M -16.9% Jul 31, 2023 10-Q 2023-09-13
Q1 2023 $8.22M -$1.63M -16.5% Apr 30, 2023 10-K 2023-07-24
Q4 2022 $8.64M Jan 31, 2023 10-Q 2023-03-16
Q3 2022 $9.25M Oct 31, 2022 10-Q 2022-12-13
Q2 2022 $9.42M Jul 31, 2022 10-Q 2022-09-12
Q1 2022 $9.85M Apr 30, 2022 10-K 2022-07-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.